Correlation Between Apex Biotechnology and Mercuries Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Apex Biotechnology and Mercuries Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apex Biotechnology and Mercuries Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apex Biotechnology Corp and Mercuries Life Insurance, you can compare the effects of market volatilities on Apex Biotechnology and Mercuries Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apex Biotechnology with a short position of Mercuries Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apex Biotechnology and Mercuries Life.

Diversification Opportunities for Apex Biotechnology and Mercuries Life

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Apex and Mercuries is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Apex Biotechnology Corp and Mercuries Life Insurance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mercuries Life Insurance and Apex Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apex Biotechnology Corp are associated (or correlated) with Mercuries Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mercuries Life Insurance has no effect on the direction of Apex Biotechnology i.e., Apex Biotechnology and Mercuries Life go up and down completely randomly.

Pair Corralation between Apex Biotechnology and Mercuries Life

Assuming the 90 days trading horizon Apex Biotechnology Corp is expected to under-perform the Mercuries Life. But the stock apears to be less risky and, when comparing its historical volatility, Apex Biotechnology Corp is 1.33 times less risky than Mercuries Life. The stock trades about -0.07 of its potential returns per unit of risk. The Mercuries Life Insurance is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  738.00  in Mercuries Life Insurance on September 1, 2024 and sell it today you would lose (78.00) from holding Mercuries Life Insurance or give up 10.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Apex Biotechnology Corp  vs.  Mercuries Life Insurance

 Performance 
       Timeline  
Apex Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Apex Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Apex Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Mercuries Life Insurance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mercuries Life Insurance has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Apex Biotechnology and Mercuries Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Apex Biotechnology and Mercuries Life

The main advantage of trading using opposite Apex Biotechnology and Mercuries Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apex Biotechnology position performs unexpectedly, Mercuries Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mercuries Life will offset losses from the drop in Mercuries Life's long position.
The idea behind Apex Biotechnology Corp and Mercuries Life Insurance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Transaction History
View history of all your transactions and understand their impact on performance